The Food Safety and Standards Authority of India (FSSAI) has initiated regulatory action against six nutraceutical manufacturers, including suspending licences over serious food safety violations discovered during inspections of their manufacturing facilities. The action targets companies accused of using expired raw materials, manufacturing products with unauthorised ingredients, exceeding permitted vitamin limits and maintaining unhygienic production conditions.

The six companies named by the regulator are Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare and Vedant Remedies. FSSAI also identified specific products and manufacturing deficiencies, publishing photographs of unhygienic conditions found at certain premises. The enforcement action comes as the regulator intensifies scrutiny of India’s growing nutraceutical and health supplement industry.

FSSAI Takes Action Against Six Nutraceutical Manufacturers

FSSAI announced the regulatory action on November 16, 2026, highlighting multiple violations involving product formulation, ingredient safety, labelling, hygiene and manufacturing standards.

The six manufacturers identified by the regulator are:

  1. Airen Herbals
  2. Aquabliss Lifesciences
  3. Raskam Healthcare
  4. Supercure Biotech
  5. Ambico Ayurvedic Healthcare
  6. Vedant Remedies

The violations differed across manufacturers. Some involved products containing excessive quantities of vitamins and minerals, while others concerned unauthorised ingredients, expired materials and inadequate hygiene practices.

FSSAI said its inspections had identified serious food safety deficiencies and that regulatory action, including licence suspensions, had been initiated.

The action is part of a wider enforcement effort aimed at ensuring that food businesses comply with India’s food safety regulations.

What Violations Did FSSAI Find?

The regulator identified different compliance failures at each manufacturing company.

The findings included problems with product composition, ingredient declarations, manufacturing practices and the storage of raw materials.

CompanyKey violations identified
Airen HerbalsExcessive vitamin and mineral levels, unauthorised product claims and labelling violations
Aquabliss LifesciencesExpired raw materials and poor sanitation
Raskam HealthcareUse of an unapproved ingredient and inadequate records
Supercure BiotechExcessive biotin, misleading product composition and non-permitted probiotic strains
Ambico Ayurvedic HealthcareExpired ingredients and unhygienic manufacturing conditions
Vedant RemediesExpired flavouring materials, sanitation deficiencies and inadequate infrastructure

The findings show that FSSAI’s concerns extend beyond product labels. The regulator has also raised questions about manufacturing processes, ingredient quality, testing arrangements and the systems used to maintain food safety.

Airen Herbals Products Found With Excessive Nutrient Levels

FSSAI identified violations in two products manufactured by Airen Herbals: Lycowey Syrup and Maxford Pain Relief.

The regulator found that Lycowey Syrup contained thiamin, vitamin E acetate, copper, selenium and zinc at levels exceeding the prescribed Recommended Dietary Allowance (RDA) limits per serving.

RDA refers to the recommended daily intake of a nutrient for maintaining nutritional requirements. Nutraceutical manufacturers must comply with the applicable limits when formulating and marketing their products.

The second product, Maxford Pain Relief, was flagged for unauthorised knee-relief claims and imagery suggesting relief from knee pain.

FSSAI also found that its thiamin content exceeded the prescribed RDA per serving and that the declaration of botanical ingredients did not comply with nutraceutical regulations.

The findings highlight the importance of ensuring that nutritional supplements contain permitted ingredient quantities and do not make unauthorised medicinal or therapeutic claims.

Aquabliss Lifesciences and Ambico Flagged for Expired Ingredients

FSSAI identified manufacturing and storage-related violations at Aquabliss Lifesciences and Ambico Ayurvedic Healthcare.

At Aquabliss Lifesciences, inspectors found expired raw materials stored at the manufacturing premises. The regulator also reported poor sanitary and hygienic conditions.

Ambico Ayurvedic Healthcare was similarly flagged for using expired materials or ingredients in nutraceutical preparations.

The company was also found to have poor sanitary and hygienic conditions at its manufacturing facility.

Expired raw materials can create food safety risks because their quality, stability and suitability for use may no longer be assured.

Manufacturers are expected to maintain appropriate inventory controls, storage conditions and traceability systems to prevent expired or unsuitable ingredients from entering production.

Raskam Healthcare Flagged for Unapproved Shilajit Ingredient

FSSAI identified the use of an unapproved ingredient, Shilajit, in products manufactured by Raskam Healthcare.

The regulator also flagged deficiencies in the company’s records and documentation.

Shilajit is a naturally occurring substance commonly used in traditional wellness products and marketed in various supplement formulations. However, ingredients used in nutraceuticals must comply with the applicable FSSAI regulations and approval requirements.

The use of an ingredient without the necessary regulatory authorisation can create compliance and safety concerns.

Manufacturers must ensure that every ingredient used in their products is permitted under the relevant food safety framework and that the required supporting documentation is maintained.

Supercure Biotech Faces Multiple Product-Related Violations

Supercure Biotech was among the manufacturers where FSSAI identified several product formulation and labelling issues.

The regulator flagged Gemkolin 9G softgel capsules for containing 100 micrograms of biotin, exceeding the maximum permitted RDA limit of 40 micrograms.

Its Vitamin E softgel capsule was also found to contain wheat germ oil instead of vitamin E, making the product name misleading.

FSSAI additionally identified failures involving food additive declarations and the specification of vitamin E limits under the applicable nutraceutical regulations.

Another product, Superbiotic capsules, was found to contain non-permitted and pathogenic microbial strains.

The strains identified by the regulator included:

  • Lactobacillus sporogenes
  • Streptococcus faecalis
  • Clostridium butyricum
  • Bacillus mesentericus

The findings raise concerns about product composition, ingredient permissions and the quality-control systems used during supplement manufacturing.

For probiotic products in particular, manufacturers must ensure that the microbial strains used comply with applicable regulatory requirements.

Vedant Remedies Flagged for Expired Flavouring Materials

FSSAI also identified manufacturing deficiencies at Vedant Remedies involving its artificial Cardamom Flavouring and Strawberry Flavouring products.

The regulator found that expired materials had been used in manufacturing.

Other deficiencies included poor sanitation and housekeeping, inadequate manufacturing infrastructure and insufficient testing arrangements.

Testing and quality assurance are important parts of food manufacturing because they help identify contamination, formulation errors and other problems before products reach consumers.

The findings suggest that FSSAI’s concerns at Vedant Remedies extended beyond individual ingredients to the overall manufacturing and quality-control environment.

Why FSSAI Is Increasing Scrutiny of Nutraceutical Companies

Nutraceuticals are products derived from food ingredients, extracts, isolates and purified compounds that provide physiological or nutritional benefits.

They include a wide range of products, such as:

  • Vitamin and mineral supplements
  • Herbal and botanical formulations
  • Protein and nutrition supplements
  • Probiotic products
  • Special dietary supplements
  • Products containing concentrated food-derived ingredients

These products have become increasingly popular among consumers seeking support for nutrition, fitness and general wellness.

However, nutraceuticals are regulated as food products under the FSSAI framework and cannot automatically make medicinal claims associated with drugs.

The Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016, establish requirements for the manufacture, composition, labelling and sale of these products.

FSSAI has also recently highlighted concerns about non-compliance with mandatory warning statements and labelling requirements for botanical ingredients.

In an October 15 advisory, the regulator reminded manufacturers that warnings must be prominent, clear and legible, particularly where specific ingredients may not be suitable for certain consumer groups.

The latest enforcement action indicates that the regulator is examining not only product claims but also the underlying manufacturing and quality-control systems.

What the Action Means for India’s Nutraceutical Industry

The regulatory action could increase compliance pressure on nutraceutical manufacturers, particularly smaller businesses that may need to strengthen their manufacturing infrastructure and quality-assurance systems.

Companies operating in the sector must ensure that their products meet prescribed nutrient limits, use permitted ingredients and carry accurate declarations.

They must also maintain appropriate hygiene standards, conduct required testing and keep records that demonstrate compliance with food safety regulations.

For established manufacturers, the action reinforces the importance of maintaining consistent quality across production facilities and product categories.

For smaller companies, it highlights the potential consequences of inadequate documentation, expired ingredients and insufficient testing arrangements.

The action may also encourage greater scrutiny by distributors, online marketplaces and consumers when selecting health supplements.

The Bigger Picture

India’s nutraceutical market has expanded as consumers increasingly purchase products aimed at improving nutrition, fitness and general well-being. This growth has created opportunities for manufacturers, wellness brands and online supplement retailers.

However, the latest FSSAI findings demonstrate why product safety and regulatory compliance are important as the industry grows. Supplements may be marketed as wellness products, but their ingredients, nutritional composition and manufacturing conditions still need to meet established food safety standards.

The six-company action also highlights the difference between making a product available in the market and demonstrating that it has been manufactured under appropriate safety and quality controls.

For consumers, accurate labelling, permitted ingredients and reliable manufacturing practices are essential when choosing nutraceutical products. For manufacturers, stronger quality assurance and regulatory compliance will be increasingly important to maintaining consumer confidence.

Looking Ahead

FSSAI’s latest action is likely to keep nutraceutical manufacturers under closer regulatory scrutiny. Companies operating in the sector will need to review ingredient permissions, nutrient concentrations, product claims, manufacturing hygiene and documentation to ensure compliance. The consequences for the six manufacturers will depend on the specific regulatory orders and subsequent compliance proceedings.

The wider impact could extend across India’s health supplement industry, encouraging manufacturers to strengthen testing facilities, improve raw material traceability and invest in better production standards. As the market expands, the ability to demonstrate product safety and regulatory compliance will remain essential for businesses seeking to build long-term consumer trust.

Get the day’s top stories in your inbox

One concise email. No spam, unsubscribe anytime.